Stock Analiz

Kura Oncology, Inc. (KURA) stock forecast and price target

Price $7.77 · data as of November 13, 2026

12-month price target

Average target$32.00
Upside / downside+311.8%
Analysts13
ConsensusStrong buy
Low $15.00Average $32.00High $76.00

Gold marker: average target · white marker: today’s price ($7.77)

Analyst ratings

Strong buy 3Buy 12Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.21−1.0%$94M
Next fiscal year
ends December 31, 2027
$-2.39+25.6%$200M
Next quarter
ends December 31, 2026
$-0.81+11.9%$32M
Quarter after
ends March 31, 2027
$-0.69—$39M

Consensus of the analysts covering Kura Oncology, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Kura Oncology stock price target?

The average 12-month target from 13 analysts is $32.00, 311.8% above the current price of $7.77 Targets range from $15.00 to $76.00.

Is Kura Oncology a buy according to analysts?

The consensus rating is “Strong buy” (3 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Kura Oncology expected to earn?

Analysts expect EPS of $-3.21 for the fiscal year ending December 31, 2026 and $-2.39 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.